TrialCancer2021

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia.

Wendy Stock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.